The effect of glutamine on oxidative damage in an experimental abdominal compartment syndrome model in rats;Sıçanlarda oluşturulan deneysel abdominal kompartman sendromunda glutaminin oksidatif hasar üzerindeki etkileri

Ulusal Travma ve Acil Cerrahi Dergisi

Volumn 17, Issue 1, 2011, Pages 1-8

  Tihan, Deniz Necdet ^a   Erbil, Yeşim ^a   Seven, Ridvan ^a   Arkaya, Selda ^a   Türkoǧlu, Ümit ^a   Hepgül, Gülçin ^b   Borucu, Ismail ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b BAGCILAR TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Abdominal compartment syndrome; Antioxidant; Glutamine; Glutathione; Ischemia; Malondialdehyde; Myeloperoxidase; Oxidative stress; Reperfusion

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUTAMINE; GLUTATHIONE; MALONALDEHYDE; MYELOPEROXIDASE;

ABDOMINAL COMPARTMENT SYNDROME; ABDOMINAL PRESSURE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; INTESTINE; INTRAABDOMINAL HYPERTENSION; LIVER; LUNG; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; REPERFUSION INJURY; WISTAR RAT;

EID: 79251556899     PISSN: 1306696X     EISSN: None     Source Type: Journal    
DOI: 10.5505/tjtes.2011.73555     Document Type: Article

References (56)

1. Cullen DJ, Coyle JP, Teplick R, Long MC. Cardiovascular, pulmonary, and renal effects of massively increased intraabdominal pressure in critically ill patients. Crit Care Med 1989;17:118-21.
2. Chen RJ, Fang JF, Chen MF. Intra-abdominal pressure monitoring as a guideline in the nonoperative management of blunt hepatic trauma. J Trauma 2001;51:44-50.
3. Asensio JA, Ceballos J, Forno W. Intra-abdominal pressure monitoring. In: WC Shoemaker, GC Velhamos, D Demetriades, editors. Procedures and monitoring for the critically ill. Philadelphia: W.B. Saunders; 2002. p. 99-103.
4. Ivatury RR, Diebel L, Porter JM, Simon RJ. Intra-abdominal hypertension and the abdominal compartment syndrome. Surg Clin North Am 1997;77:783-800.
5. Kumar V, Cotran RS, Robbins SL. Basic pathology. Philadelphia: W.B. Saunders; 1992. p. 4-11.
6. Clarkson AN, Sutherland BA, Appleton I. The biology and pathology of hypoxia-ischemia: an update. Arch Immunol Ther Exp (Warsz) 2005;53:213-25.
7. de Groot H, Rauen U. Ischemia-reperfusion injury: processes in pathogenetic networks: a review. Transplant Proc 2007;39:481-4.
8. Ley K, Reutershan J. Leucocyte-endothelial interactions in health and disease. Handb Exp Pharmacol 2006:97-133.
9. Gutteridge JM, Halliwell B. Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci 2000;899:136-47.
10. Rodwell VW. Metabolism of proteins and aminoacids. In: Murray RK, Granner DK, Mayes PA, Rodwell VW, editors. Harper's biochemistry. Appleton&Lange; 1990. p. 333-412.
11. Tapiero H, Mathé G, Couvreur P, Tew KD. II. Glutamine and glutamate. Biomed Pharmacother. 2002;56:446-57.
12. Young VR, Ajami AM. Glutamine: the emperor or his clothes? J Nutr 2001;131:2449S-87S.
13. Guloglu R, Berber E, Taviloglu K, Gunay K, Ertekin C. Clinical importance of intraabdomainal pressure in the sugical intensive care. Eur J Emerg Surg Int Care 1997;20:191-4.
14. Saggi BH, Sugerman HJ, Ivatury RR, Bloomfield GL. Abdominal compartment syndrome. J Trauma 1998;45:597-609.
15. Van Hee R. An abdominal challenge: the compartment syndrome. G Chir 2007;28:413-8.
16. Eddy V, Nunn C, Morris JA Jr. Abdominal compartment syndrome. The Nashville experience. Surg Clin North Am 1997;77:801-12.
17. Schein M, Wittmann DH, Aprahamian CC, Condon RE. The abdominal compartment syndrome: the physiological and clinical consequences of elevated intra-abdominal pressure. J Am Coll Surg 1995;180:745-53.
18. Mendoza-Sagaon M, Hanly EJ, Talamini MA, Kutka MF, Gitzelmann CA, Herreman-Suquet K, et al. Comparison of the stress response after laparoscopic and open cholecystectomy. Surg Endosc 2000;14:1136-41.
19. Akbulut G, Polat C, Aktepe F, Yilmaz S, Kahraman A, Serteser M, et al. The oxidative effect of prolonged CO2 pneumoperitoneum on renal tissue of rats. Surg Endosc 2004;18:1384-8.
20. Huang Y, Li N, Liboni K, Neu J. Glutamine decreases lipopolysaccharide-induced IL-8 production in Caco-2 cells through a non-NF-kappaB p50 mechanism. Cytokine 2003;22:77-83.
21. Jobin C, Sartor RB. The I kappa B/NF-kappa B system: a key determinant of mucosalinflammation and protection. Am J Physiol Cell Physiol 2000;278:451-62.
22. Schmid RM, Adler G. NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases. Gastroenterology.2000;118:1208-28.
23. Oda J, Ivatury RR, Blocher CR, Malhotra AJ, Sugerman HJ. Amplified cytokine response and lung injury by sequential hemorrhagic shock and abdominal compartment syndrome in a laboratory model of ischemia-reperfusion. J Trauma 2002;52:625-32.
24. Neu J, Li N. Pathophysiology of glutamine and glutamate metabolism in premature infants. Curr Opin Clin Nutr Metab Care 2007;10:75-9.
25. Ziegler TR, Bazargan N, Leader LM, Martindale RG. Glutamine and the gastrointestinal tract. Curr Opin Clin Nutr Metab Care 2000;3:355-62.
26. Laight DW, Lad N, Woodward B, Waterfall JF. Assessment of myeloperoxidase activity in renal tissue after ischemia/reperfusion. Eur J Pharmacol 1994;292:81-8.
27. Roth E, Oehler R, Manhart N, Exner R, Wessner B, Strasser E, et al. Regulative potential of glutamine--relation to glutathione metabolism. Nutrition 2002;18:217-21.
28. Valencia E, Hardy G. Practicalities of glutathione supplementation in nutritional support. Curr Opin Clin Nutr Metab Care 2002;5:321-6.
29. Fläring UB, Rooyackers OE, Wernerman J, Hammarqvist F. Glutamine attenuates post-traumatic glutathione depletion in human muscle. Clin Sci (Lond) 2003;104:275-82.
30. Reiter RJ, Tan DX, Osuna C, Gitto E. Actions of melatonin in the reduction of oxidative stress. A review. J Biomed Sci.2000;7:444-58.
31. Reiter RJ, Tan DX, Manchester LC, Qi W. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys 2001;34:237-56.
32. Erbil Y, Oztezcan S, Giris M, Barbaros U, Olgaç V, Bilge H, et al. The effect of glutamine on radiation-induced organ damage. Life Sci 2005;78:376-82.
33. Daniele B, Perrone F, Gallo C, Pignata S, De Martino S, De Vivo R, et al. Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial. Gut 2001;48:28-33.
34. Labow BI, Souba WW. Glutamine. World J Surg 2000;24:1503-13.
35. Reeds PJ, Burrin DG. Glutamine and the bowel. J Nutr 2001;131:2505-24.
36. Karinch AM, Pan M, Lin CM, Strange R, Souba WW. Glutamine metabolism in sepsis and infection. J Nutr 2001;131:2535-51.
37. Peng X, Yan H, You Z, Wang P, Wang S. Effects of enteral supplementation with glutamine granules on intestinal mucosal barrier function in severe burned patients. Burns 2004;30:135-9.
38. Boelens PG, Houdijk AP, Fonk JC, Puyana JC, Haarman HJ, von Blomberg-van der Flier ME, et al. Glutamine-enriched enteral nutrition increases in vitro interferon-gamma production but does not influence the in vivo specific antibody response to KLH after severe trauma. A prospective, double blind, randomized clinical study. Clin Nutr 2004;23:391-400.
39. García-de-Lorenzo A, Zarazaga A, García-Luna PP, Gonzalez- Huix F, López-Martínez J, Miján A, et al. Clinical evidence for enteral nutritional support with glutamine: a systematic review. Nutrition 2003;19:805-11.
40. Bolotin G, Raman J, Williams U, Bacha E, Kocherginsky M, Jeevanandam V. Glutamine improves myocardial function following ischemia-reperfusion injury. Asian Cardiovasc Thorac Ann 2007;15:463-7.
41. Hulsewé KW, van Acker BA, Hameeteman W, van der Hulst RR, Vainas T, Arends JW, et al. Does glutamine-enriched parenteral nutrition really affect intestinal morphology and gut permeability? Clin Nutr 2004;23:1217-25.
42. Ikeda S, Zarzaur BL, Johnson CD, Fukatsu K, Kudsk KA. Total parenteral nutrition supplementation with glutamine improves survival after gut ischemia/reperfusion. JPEN J Parenter Enteral Nutr 2002;26:169-73.
43. Yeh SL, Lai YN, Shang HF, Lin MT, Chen WJ. Effects of glutamine supplementation on innate immune response in rats with gut-derived sepsis. Br J Nutr 2004;91:423-9.
44. Chang WK, Yang KD, Chuang H, Jan JT, Shaio MF. Glutamine protects activated human T cells from apoptosis by up-regulating glutathione and Bcl-2 levels. Clin Immunol 2002;104:151-60.
45. Pithon-Curi TC, Schumacher RI, Freitas JJ, Lagranha C, Newsholme P, Palanch AC, et al. Glutamine delays spontaneous apoptosis in neutrophils. Am J Physiol Cell Physiol 2003;284:1355-61.
46. Ran Q, Liang H, Gu M, Qi W, Walter CA, Roberts LJ 2nd, et al. Transgenic mice overexpressing glutathione peroxidase 4 are protected against oxidative stress-induced apoptosis. J Biol Chem 2004;279:55137-46.
47. Kudsk KA. Current aspects of mucosal immunology and its influence by nutrition. Am J Surg 2002;183:390-8.
48. Omar R, Nomikos I, Piccorelli G, Savino J, Agarwal N. Prevention of postischaemic lipid peroxidation and liver cell injury by iron chelation. Gut 1989;30:510-4.
49. Sumimoto K, Oku J, Dohi K, Kawasaki T. Lipid peroxidation in transplanted rat liver. Transplant Proc 1990;22:2023-4.
50. Kaçmaz A, Polat A, User Y, Tilki M, Ozkan S, Sener G. Octreotide improves reperfusion-induced oxidative injury in acute abdominal hypertension in rats. J Gastrointest Surg 2004;8:113-9.
51. Wasa M, Soh H, Shimizu Y, Fukuzawa M. Glutamine stimulates amino acid transport during ischemia-reperfusion in human intestinal epithelial cells. J Surg Res 2005;123:75-81.
52. Melis GC, ter Wengel N, Boelens PG, van Leeuwen PA. Glutamine: recent developments in research on the clinical significance of glutamine. Curr Opin Clin Nutr Metab Care 2004;7:59-70.
53. Bouteloup-Demange C, Claeyssens S, Maillot C, Lavoinne A, Lerebours E, Dechelotte P. Effects of enteral glutamine on gut mucosal protein synthesis in healthy humans receiving glucocorticoids. Am J Physiol Gastrointest Liver Physiol 2000;278:677-81.
54. Wischmeyer PE, Kahana M, Wolfson R, Ren H, Musch MM, Chang EB. Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia. Shock 2001;16:398-402.
55. McCauley R, Kong SE, Heel K, Hall JC. The role of glutaminase in the small intestine. Int J Biochem Cell Biol 1999;31:405-13.
56. Erman F, Balkan J, Cevikbas U, Koçak-Toker N, Uysal M. Betaine or taurine administration prevents fibrosis and lipid peroxidation induced by rat liver by ethanol plus carbon tetrachloride intoxication. Amino Acids 2004;27:199-205.